FDA approves ketamine-like nasal spray for depression

National
esketamine-fda-decision CREDIT Janssen Pharmaceuticals Inc._1551875630569.jpg.jpg

The FDA has now approved an anti-depressant that contains a substance similar to ketamine, a powerful anesthetic used in the illegal party drug known as “Special K.” 

The nasal spray will be sold as “Spravato.” It is meant for patients who have tried at least two other anti-depressants and have not seen success. 

“Spravato” will only be used in medical offices where patients must be monitored for two hours following treatment. 

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Download our news app

Get it on Google Play